Zobrazeno 1 - 10
of 40
pro vyhledávání: '"B Abhishekh"'
Publikováno v:
Asian Journal of Transfusion Science, Vol 15, Iss 1, Pp 100-103 (2021)
Detection of clinically significant alloantibodies during pretransfusion testing is essential before any blood transfusion. Sometimes, clinically insignificant antibodies unrelated to blood group antigen may interfere with routine testing. Their inte
Externí odkaz:
https://doaj.org/article/68bab9976e324cd2be23d31ca491bc55
Autor:
Remi Remakanth, B Abhishekh
Publikováno v:
Asian Journal of Transfusion Science, Vol 15, Iss 1, Pp 97-99 (2021)
A 40-year-old male patient presented to the emergency department with complaints of anasarca, mild dyspnea, orthopnea, vomiting, and decreased urine output. A provisional diagnosis of chronic kidney disease was made and planned for hemodialysis. In v
Externí odkaz:
https://doaj.org/article/2dcd644f3cfd42419281b3abe2bc8c34
Autor:
R Loganathan, B Abhishekh
Publikováno v:
Asian Journal of Transfusion Science, Vol 16, Iss 1, Pp 156-157 (2022)
Externí odkaz:
https://doaj.org/article/3842dcdbcd11464286846642999e3b4c
Publikováno v:
Global Journal of Transfusion Medicine, Vol 4, Iss 2, Pp 204-207 (2019)
Background: Indian Drugs and Cosmetics Act and Rules 1945 states that 1% or 4 units/month of any components prepared and stored should meet specific quality control parameter. Currently, our blood center relies on nonancillary tests such as prothromb
Externí odkaz:
https://doaj.org/article/993dadf7d9154eb4858ca9ee8a0c42cf
Autor:
Remi Remakanth, B Abhishekh
Publikováno v:
Global Journal of Transfusion Medicine, Vol 5, Iss 2, Pp 206-208 (2020)
Background: Injudicious over-ordering of blood components not only burdens the physical and human resources but also increases the cost of health care. Moreover, such practices have a greater implication in developing countries like ours where there
Externí odkaz:
https://doaj.org/article/513c6e15e7d44abfaa6242fe00e73f5e
Publikováno v:
Global Journal of Transfusion Medicine, Vol 5, Iss 2, Pp 225-227 (2020)
Daratumumab (DARA) is an anti-CD38 monoclonal antibody which has promising results in relapsed and refractory multiple myeloma. DARA interferes with blood compatibility testing by causing panagglutination in the indirect antiglobulin test. In all inc
Externí odkaz:
https://doaj.org/article/a7e7b14ffcde4ecea7663e597eb846ec
Publikováno v:
Indian Journal of Hematology and Blood Transfusion. 39:308-316
Publikováno v:
Asian Journal of Transfusion Science
Asian Journal of Transfusion Science, Vol 15, Iss 1, Pp 100-103 (2021)
Asian Journal of Transfusion Science, Vol 15, Iss 1, Pp 100-103 (2021)
Detection of clinically significant alloantibodies during pretransfusion testing is essential before any blood transfusion. Sometimes, clinically insignificant antibodies unrelated to blood group antigen may interfere with routine testing. Their inte
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Annals of Pathology and Laboratory Medicine. 7:A496-501
Background: As per Indian drugs and cosmetic act & rules 1945 (DCA), 1% or 4 units/month of all components should meet quality control parameter. Aims and objectives: 1.) To assess the level of clotting factors FV and FIX in FFP. 2.) To identify the